About: Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.41 (-3.82%)
DYAI NASDAQ Dyadic International Inc
Dyadic International Inc share price
DYAI price activity
Last Price
$0.410
Change (24hr)
-0.02 USD (-3.57%)
Volume
32.54K
Volume (4w avg)
-
Open
$0.43
Day Range
$0.40 - $0.43
Previous Close
$0.42
Last Trade
13 Oct, 5:46 pm GMT+0
Delayed
13 Oct, 5:46 pm GMT+0
DYAI price performance
Delayed
13 Oct, 5:46 pm GMT+0
DYAI Market Signals